Industry NewsQIAGEN Expands Biomarker Content Portfolio to Support Molecular Diagnostics for Immuno-Oncology Therapies
Industry NewsNew Test Which Identifies Head and Neck Cancer Patients Most Likely to Benefit from Opdivo (nivolumab) is Approved for Use in Europe
Product NewsTxCell and Inserm Collaborate to Develop New CAR-Tregs in Transplantation and Multiple Sclerosis
Product NewsNew Ultra-Sensitive Multiple Protein Arrays Launched at the 13th Annual Biomarker and Diagnostic World Congress